Patient Derived Xenograft (PDX) Models Market Expects Significant Growth, Reaching $710 Million by 2028 - Global Long-term Forecasts to 2033
21 nov. 2024 11h30 HE
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Patient Derived Xenograft (PDX) Models Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The patient derived...
Silexion Therapeutics to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
20 nov. 2024 08h30 HE
|
Silexion Therapeutics Corp
GRAND CAYMAN, CAYMAN ISLANDS, Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers,...
Precision Medicine Software Market Report 2024-2029: Industry Trends, Business Opportunities, Competitive Intelligence, Regional Growth Forecasts
31 oct. 2024 07h43 HE
|
Research and Markets
Dublin, Oct. 31, 2024 (GLOBE NEWSWIRE) -- The "Precision Medicine Software Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The Precision Medicine...
Modifi Biosciences Acquired by Merck
23 oct. 2024 07h05 HE
|
Modifi Biosciences
NEW HAVEN, Conn., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Modifi Biosciences, Inc. (“Modifi Biosciences”), a leader in the development of direct DNA modification enabled cancer therapeutics, today...
Antineoplastic Agents (Anticancer Drugs) Research Report 2024: Global Market to Surpass $225 Billion by 2030 - Growing Focus on Rare Cancers and Orphan Drug Development Generates New Opportunities
21 oct. 2024 04h11 HE
|
Research and Markets
Dublin, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The "Antineoplastic Agents - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Leapfrog Bio Announces Publication in Nature PJ Precision Oncology Validating its Proprietary Precision PGx Platform™
05 sept. 2024 07h00 HE
|
Leapfrog Bio
Leapfrog Bio today announced a publication in Nature PJ Precision Oncology describing and validating its Precision PGx Platform™
ITM Raises €188m to Enhance Radiopharmaceutical Pipeline and to Strengthen Leading Position in Medical Radioisotope Manufacturing
06 juin 2024 05h00 HE
|
ITM Isotope Technologies Munich SE
Proceeds to support development of ITM’s targeted radiopharmaceutical pipeline and preparations for potential market launch of phase III lead candidate, ITM-11, as it nears clinical read-out Funds...
Global Oncolytic Virotherapy Market Research 2024: Industry Size, Share, Trends, Opportunity & Forecasts, 2019-2029 - Focus on Personalized Medicine, Clinical Advancements Spurs Growth
14 mai 2024 10h24 HE
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Oncolytic Virotherapy Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F" report has been added to ...
$163 Billion Precision Oncology Markets - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2023 & 2024-2029F
14 mai 2024 02h52 HE
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Precision Oncology Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F" report has been added to ...
Metagenomics Market Size, Share & Trends Analysis Report 2024-2030: Emergence of New Fields in Genomics that Complement Metagenomics Fueling Expansion
13 mai 2024 10h02 HE
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Metagenomics Market Size, Share & Trends Analysis Report By Technology (Shotgun Sequencing, Whole Genome Sequencing), By Product, By Workflow, By...